Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IDM Pharma
Irvine, California, United Statesidm-pharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
IDM Pharma developed innovative immunotherapies for cancer, aiming to activate the immune system against tumors. The company had several programs in clinical development and completed asset sales related to infectious disease programs before being acquired. It was known for leveraging adaptive immune responses and therapeutic vaccines[1][3][5]. No recent clinical results are available as the company has been acquired and no longer operates independently.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Immunotherapytherapeutic vaccines (cancer immunotherapies)
- Industry
- Biotech
02
Partnerships
Innogenetics NV/SA – collaboration on next-generation therapeutic vaccines[1]Pharmexa A/S – sale of infectious disease assets[1]
Beyond the preview
Go deeper on IDM Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDM Pharma.